Our mission is to offer the first influenza vaccine approved for children younger than 2 year that, in a natural way, provides double protection

Latest news

Highlights

In this short video Dr. Anna-Karin Maltais, Chief Scientific Officer at Eurocine Vaccines explains why a better influenza vaccine is needed for younger children

Or, learn more about nasal vaccination for children here =>

One of the strengths of Eurocine Vaccines are the people comitted to the mission improving the vaccine industry. Here the Board of Directors share their views on the spirit and vison of the company.

Or, read more about the Board here =>

Calendar

Do you want to follow Eurocine Vaccines development?

Share our ambition developing more effective vaccines. Fill in your e-mail address and we will update you with the latest Press Releases, Financial information and stories.